PHP53 PATIENTS USING SPECIALTY PHARMACIES FOR A TUMOR NECROSIS FACTOR ANTAGONIST HAD GREATER REFILL ADHERENCE THAN THOSE USING A RETAIL PHARMACIES
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72433-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)72433-5/fulltext
Section Title :
Section Order :
1041
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72433-5&doi=10.1016/S1098-3015(10)72433-5